Physician profile
Bryan E Anderson
NPI 1942264155
$9,707.68
in general payments reported to CMS, 2019-2025
12 companies · $9,040 in 2025
The $9,040 reported for 2025 was more than what 92% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $119 · 2020: $86.75 · 2021: $50.08 · 2022: $144 · 2023: $163 · 2024: $104 · 2025: $9,040.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,400 · Travel and Lodging: $1,939 · Food and Beverage: $969.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,400.00 |
| Travel and Lodging | $1,938.65 |
| Food and Beverage | $968.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $7,512.72 | 2025 | |
| Insmed, INC. | $1,423.31 | 2025 | |
| Zimmer Biomet Holdings, INC. | $163.41 | 2020-2022 | |
| Bioventus LLC | $130.00 | 2023 | Bonescalpel |
| Pacira Therapeutics, INC. | $106.16 | 2019 | |
| Globus Medical, INC. | $104.09 | 2024 | Fortify, Creo S2ai, Creo Threaded |
| Stryker Corporation | $94.03 | 2021-2022 | |
| Abbvie INC. | $67.66 | 2025 | |
| Medtronic, INC. | $36.44 | 2025 | T2 Stratosphere Expandable Corpectomy System |
| Smith+Nephew, INC. | $33.21 | 2023 | Pico, Stravix, Collagenase Santyl |
| Kyowa Kirin, INC. | $23.50 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $13.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.